{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:28:57Z","timestamp":1794666537061,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pheochromocytoma\/paraganglioma (PPGL)-induced catecholamine crisis is a rare endocrine emergency leading to life-threatening hemodynamic instability causing end-organ damage or dysfunction. As it is associated with a significant mortality rate of approximately 15%, recognizing the signs and symptoms and making the appropriate diagnosis are critical. For this purpose, we report the clinical course of the crisis in four out of a total of six patients with a PPGL crisis from a cohort of 199 PPGL patients of a single tertiary referral center for PPGL patients in the Netherlands diagnosed between 2002 and 2020. Successful treatment of a PPGL crisis demands prompt diagnosis, vigorous pharmacological therapy, and emergency tumor removal if the patient continues to deteriorate.<\/jats:p>","DOI":"10.1007\/s42000-021-00274-6","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:22:30Z","timestamp":1613089350000},"page":"395-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pheochromocytoma\/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1899-6531","authenticated-orcid":false,"given":"Anouk C","family":"Meijs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Snel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora P M","family":"Corssmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"issue":"1","key":"274_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/cen.12324","volume":"80","author":"BC Whitelaw","year":"2014","unstructured":"Whitelaw BC et al (2014) Phaeochromocytoma [corrected] crisis. Clin Endocrinol (Oxf) 80(1):13\u201322","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"274_CR2","first-page":"802","volume":"58","author":"CM Beard","year":"1983","unstructured":"Beard CM et al (1983) Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 58(12):802\u2013804","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"274_CR3","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1177\/0310057X1003800621","volume":"38","author":"PA Davlouros","year":"2010","unstructured":"Davlouros PA et al (2010) Fever with multiple organ failure: not always sepsis. Anaesth Intensive Care 38(6):1090\u20131093","journal-title":"Anaesth Intensive Care"},{"issue":"3","key":"274_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ki.1991.244","volume":"40","author":"EL Bravo","year":"1991","unstructured":"Bravo EL (1991) Pheochromocytoma: new concepts and future trends. Kidney Int 40(3):544\u2013556","journal-title":"Kidney Int"},{"issue":"1","key":"274_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00005792-199101000-00004","volume":"70","author":"PP Stein","year":"1991","unstructured":"Stein PP, Black HR (1991) A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution\u2019s experience. Med (Baltimore) 70(1):46\u201366","journal-title":"Med (Baltimore)"},{"issue":"8","key":"274_CR6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1001\/archsurg.1988.01400320042007","volume":"123","author":"KA Newell","year":"1988","unstructured":"Newell KA et al (1988) Pheochromocytoma multisystem crisis: a surgical emergency. Arch Surg 123(8):956\u2013959","journal-title":"Arch Surg"},{"issue":"2","key":"274_CR7","first-page":"153","volume":"67","author":"K Juszczak","year":"2014","unstructured":"Juszczak K, Drewa T (2014) Adrenergic crisis due to pheochromocytoma - practical aspects. A short review. Cent European J Urol 67(2):153\u2013155","journal-title":"Cent European J Urol"},{"issue":"1","key":"274_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.currproblcancer.2014.01.001","volume":"38","author":"VL Martucci","year":"2014","unstructured":"Martucci VL, Pacak K (2014) Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer 38(1):7\u201341","journal-title":"Curr Probl Cancer"},{"issue":"3","key":"274_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/BF03401315","volume":"12","author":"A Dijkhuizen","year":"2013","unstructured":"Dijkhuizen A et al (2013) Hypertensive crisis during adrenalectomy in a patient with pheochromocytoma and a HOCM with SAM. Horm (Athens) 12(3):472\u2013474","journal-title":"Horm (Athens)"},{"issue":"9563","key":"274_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0140-6736(07)60365-1","volume":"369","author":"JR van Lennep","year":"2007","unstructured":"van Lennep JR, Romijn JA, Harinck HI (2007) Multi-organ failure after a glucagon test. Lancet 369(9563):798","journal-title":"Lancet"},{"issue":"6","key":"274_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1530\/EJE-15-0483","volume":"173","author":"A Riester","year":"2015","unstructured":"Riester A et al (2015) Life-threatening events in patients with pheochromocytoma. Eur J Endocrinol 173(6):757\u2013764","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"274_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/jc.2012-3020","volume":"98","author":"A Scholten","year":"2013","unstructured":"Scholten A et al (2013) Pheochromocytoma crisis is not a surgical emergency. J Clin Endocrinol Metab 98(2):581\u2013591","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"274_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jamcollsurg.2009.09.022","volume":"209","author":"MA Guerrero","year":"2009","unstructured":"Guerrero MA et al (2009) Clinical spectrum of pheochromocytoma. J Am Coll Surg 209(6):727\u2013732","journal-title":"J Am Coll Surg"},{"issue":"3","key":"274_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1399-0004.2011.01653.x","volume":"81","author":"EF Hensen","year":"2012","unstructured":"Hensen EF et al (2012) High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands. Clin Genet 81(3):284\u2013288","journal-title":"Clin Genet"},{"issue":"1","key":"274_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1530\/EJE-10-0114","volume":"163","author":"N van Duinen","year":"2010","unstructured":"van Duinen N et al (2010) Pheochromocytomas detected by biochemical screening in predisposed subjects are associated with lower prevalence of clinical and biochemical manifestations and smaller tumors than pheochromocytomas detected by signs and symptoms. Eur J Endocrinol 163(1):121\u2013127","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"274_CR16","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.4158\/EP10388.CR","volume":"17","author":"A Hosseinnezhad","year":"2011","unstructured":"Hosseinnezhad A et al (2011) Glucagon-induced pheochromocytoma crisis. Endocr Pract 17(3):e51\u2013e54","journal-title":"Endocr Pract"},{"issue":"6","key":"274_CR17","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(6):1915\u20131942","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"274_CR18","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.4158\/EP11346.CR","volume":"18","author":"S Subramanyam","year":"2012","unstructured":"Subramanyam S, Kreisberg RA (2012) Pheochromocytoma: a cause of ST-segment elevation myocardial infarction, transient left ventricular dysfunction, and takotsubo cardiomyopathy. Endocr Pract 18(4):e77\u2013e80","journal-title":"Endocr Pract"},{"key":"274_CR19","doi-asserted-by":"crossref","unstructured":"Casey RT et al (2017) Management of an acute catecholamine-induced cardiomyopathy and circulatory collapse: a multidisciplinary approach. Endocrinol Diabetes Metab Case Rep 2017","DOI":"10.1530\/EDM-17-0122"},{"issue":"4","key":"274_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/clc.20680","volume":"33","author":"S Kim","year":"2010","unstructured":"Kim S et al (2010) Inverted-Takotsubo pattern cardiomyopathy secondary to pheochromocytoma: a clinical case and literature review. Clin Cardiol 33(4):200\u2013205","journal-title":"Clin Cardiol"},{"issue":"50","key":"274_CR21","doi-asserted-by":"publisher","first-page":"e2198","DOI":"10.1097\/MD.0000000000002198","volume":"94","author":"M Batisse-Lignier","year":"2015","unstructured":"Batisse-Lignier M et al (2015) Acute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses?: a systematic analytical review. Med (Baltimore) 94(50):e2198","journal-title":"Med (Baltimore)"},{"issue":"10","key":"274_CR22","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.4158\/EP171930.OR","volume":"23","author":"N Gagnon","year":"2017","unstructured":"Gagnon N et al (2017) Takotsubo-like cardiomyopathy in a large cohort of patients with pheochromocytoma and paraganglioma. Endocr Pract 23(10):1178\u20131192","journal-title":"Endocr Pract"},{"key":"274_CR23","first-page":"2397638","volume":"2019","author":"N Sharma","year":"2019","unstructured":"Sharma N et al (2019) Microangiopathic hemolytic anemia and fulminant renal failure: a rare manifestation of pheochromocytoma. Case Rep Endocrinol 2019:2397638","journal-title":"Case Rep Endocrinol"},{"key":"274_CR24","doi-asserted-by":"crossref","unstructured":"Ferreira AG et al (2019) Paraganglioma presenting as stress cardiomyopathy: case report and literature review. Endocrinol Diabetes Metab Case Rep 2019","DOI":"10.1530\/EDM-19-0017"},{"issue":"1_suppl","key":"274_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/0267659120908413","volume":"35","author":"M Matteucci","year":"2020","unstructured":"Matteucci M et al (2020) Extracorporeal life support for phaeochromocytoma-induced cardiogenic shock: a systematic review. Perfusion 35(1_suppl):20\u201328","journal-title":"Perfusion"},{"issue":"18","key":"274_CR26","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.2169\/internalmedicine.54.4732","volume":"54","author":"M Tagawa","year":"2015","unstructured":"Tagawa M et al (2015) Ventricular rhythm and hypotension in a patient with pheochromocytoma-induced myocardial damage and reverse Takotsubo cardiomyopathy. Intern Med 54(18):2343\u20132349","journal-title":"Intern Med"},{"issue":"2","key":"274_CR27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.ijcard.2014.09.082","volume":"177","author":"J Berger","year":"2014","unstructured":"Berger J et al (2014) An unexpected post-partum fulminant heart failure. Int J Cardiol 177(2):e47\u2013e48","journal-title":"Int J Cardiol"},{"key":"274_CR28","doi-asserted-by":"crossref","unstructured":"Mulla CM, Marik PE (2012) Pheochromocytoma presenting as acute decompensated heart failure reversed with medical therapy. BMJ Case Rep 2012","DOI":"10.1136\/bcr-2012-006319"},{"key":"274_CR29","doi-asserted-by":"crossref","unstructured":"Kim, J., et al., Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess. 2004. 151(6): p. 771.","DOI":"10.1530\/eje.0.1510771"},{"issue":"4","key":"274_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.4103\/2230-8210.113771","volume":"17","author":"RT Varghese","year":"2013","unstructured":"Varghese RT, John AM, Paul TV (2013) Catecholamine induced cardiomyopathy in pheochromocytoma. Indian J Endocrinol Metab 17(4):733\u2013735","journal-title":"Indian J Endocrinol Metab"},{"issue":"4","key":"274_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ecl.2006.09.014","volume":"35","author":"FM Brouwers","year":"2006","unstructured":"Brouwers FM et al (2006) Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma. Endocrinol Metab Clin North Am 35(4):699\u2013724 viii","journal-title":"Endocrinol Metab Clin North Am"},{"key":"274_CR32","doi-asserted-by":"crossref","unstructured":"Buitenwerf E et al (2019) Efficacy of alpha-blockers on hemodynamic control during pheochromocytoma resection - a randomized controlled trial. J Clin Endocrinol Metab","DOI":"10.1210\/clinem\/dgz188"},{"issue":"5","key":"274_CR33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1742-6723.2007.01007.x","volume":"19","author":"A Morton","year":"2007","unstructured":"Morton A (2007) Magnesium sulphate for phaeochromocytoma crisis. Emerg Med Australas 19(5):482","journal-title":"Emerg Med Australas"},{"issue":"3","key":"274_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1507\/endocrj.EJ17-0276","volume":"65","author":"M Naruse","year":"2018","unstructured":"Naruse M et al (2018) Efficacy and safety of metyrosine in pheochromocytoma\/paraganglioma: a multi-center trial in Japan. Endocr J 65(3):359\u2013371","journal-title":"Endocr J"},{"issue":"5","key":"274_CR35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00000658-199011000-00010","volume":"212","author":"RR Perry","year":"1990","unstructured":"Perry RR et al (1990) Surgical management of pheochromocytoma with the use of metyrosine. Ann Surg 212(5):621\u2013628","journal-title":"Ann Surg"},{"issue":"8","key":"274_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/archinte.1997.00440290087009","volume":"157","author":"J Steinsapir","year":"1997","unstructured":"Steinsapir J et al (1997) Metyrosine and pheochromocytoma. Arch Intern Med 157(8):901\u2013906","journal-title":"Arch Intern Med"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-021-00274-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T02:19:24Z","timestamp":1697854764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-021-00274-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1007\/s42000-021-00274-6","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was found to be exempt from consideration by the Medical Ethical Committee of Leiden University Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that the research participants provided informed consent for publication of their data and images in Figs.and.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}